The goal of gene therapy for patients with hemophilia A is to safely impart long-term stable factor VIII expression that predictably ameliorates bleeding with the use of the lowest possible vector ...
The Annals of Applied Statistics, Vol. 7, No. 2 (June 2013), pp. 799-822 (24 pages) Sparse latent multi-factor models have been used in many exploratory and predictive problems with high-dimensional ...
Conclusion: Expression of the cell adhesion molecule CEACAM6 in CRC is an independent prognostic factor allowing subdivision of patients into low- and high-risk groups. Whether CEACAM6 or CEA and ...
TUCKER, Ga. & ROCKVILLE, Md.--(BUSINESS WIRE)--Expression Therapeutics LLC, a biotechnology company developing high expression factor VIII technologies, together with ABL, Inc., a biomedical contract ...
Phase II Study of Dose-Adjusted EPOCH and Rituximab in Untreated Diffuse Large B-Cell Lymphoma With Analysis of Germinal Center and Post-Germinal Center Biomarkers Expression of M-CSF and density of ...
Plant steroid hormones, brassinosteroids (BRs), regulate essential growth and developmental processes. BRs signal through membranelocalized receptor BRI1 and several other signaling components to ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback